During the past decade, Cardiology Institute of Michigan conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiology Institute of Michigan" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Cardiology Institute of Michigan" are "Heart Failure" (2 trials), "Cardiovascular Disease" (1 trials), "Cardiovascular Diseases" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Cardiology Institute of Michigan" in a lesser frequency.

Most popular intervention types in "Cardiology Institute of Michigan" are "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Intense Education Intervention" (1 trials), "Trends-equipped LifeVest 4000" (1 trials) and "µCor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiology Institute of Michigan" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Cardiology Institute of Michigan". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Cardiology Institute of Michigan, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cardiology Institute of Michigan, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".